| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $5.8M | +77.4% |
| SG&A Expense | $5.3M | -30.5% |
| Operating Income | -$11.1M | -1.8% |
| Net Income | -$5.8M | +29.4% |
| EPS (Basic) | -$0.01 | +50.0% |
| EPS (Diluted) | -$0.01 | +50.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.1M | -19.0% |
| Current Assets | $14.4M | -19.5% |
| Total Assets | $27.1M | -15.5% |
| Current Liabilities | $2.3M | -4.3% |
| Stockholders' Equity | -$1.8M | -279.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.3M | +2.2% |
| Capital Expenditures | $836K | +501.4% |
| Investing Cash Flow | -$836K | -501.4% |
| Financing Cash Flow | $6.8M | -68.4% |
| Free Cash Flow | -$8.1M | -7.1% |